Medidata, a renowned provider of clinical trial solutions, has partnered with Aixial Group, a contract research organization (CRO), to enhance the efficiency of clinical studies. Aixial Group aims to establish a Single Source of Truth (SSOT) by migrating data onto the Medidata Platform. This will enable study teams to safeguard patient data, monitor patient safety, and make informed decisions throughout the study.
Integrating Medidata’s solutions will provide Aixial Group with greater operational consistency and control, leveraging Medidata Rave EDC. This advanced platform supports studies of varying complexities and durations, translating productivity into accelerated access to innovative patient treatments.
By partnering with Medidata, Aixial Group seeks to elevate its services for trial sponsors, ensuring reliability and rapid delivery of clinical research programs. The consolidated data repository will empower Aixial Group teams to deliver exceptional customer services.
This collaboration reflects Medidata’s commitment to supporting CROs in driving operational excellence and delivering exceptional research outcomes. Medidata’s solutions enable CROs to optimize processes, enhance patient safety, and meet regulatory compliance requirements.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
